Skip Navigation



Annals of Oncology Advance Access published online on November 4, 2009
Annals of Oncology, doi:10.1093/annonc/mdp513
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kanai, M.
Right arrow Articles by Chiba, T.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kanai, M.
Right arrow Articles by Chiba, T.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org

letter to the editor

Premedication with 20 mg dexamethasone effectively prevents relapse of extensive skin rash associated with gemcitabine monotherapy

The first 10% of the full text of this article appears below.

Gemcitabine treatment is commonly associated with skin rash, with a reported incidence of 7%–30% [1–3]; however, there exists only one prior report describing the management of gemcitabine-associated rash in the English-language literature [1]. When an extensive skin rash develops, both the patient and physician may . . . [Full Text of this Article]

case 1

funding

M. Kanai1,*, S. Matsumoto1, T. Nishimura1, Y. Matsumura2, E. Hatano3, A. Mori3, T. Masui3, Y. Kawaguchi3, E. Nakamura4, S. Tada5, T. Kitano1, H. Ishiguro1, K. Yanagihara1 and T. Chiba1,5

1 Outpatient Oncology Unit
2 Department of Dermatology
3 Department of Surgery
4 Department of Urology
5 Department of Gastroenterology, Kyoto University Hospital, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto, Japan

* (E-mail: kanai@kuhp.kyoto-u.ac.jp)


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?